Umbralisib antagonizes multidrug resistance in ABCB1-overexpressing cancer cells

Letao Bo, Bohan Zhang, Xuan-Yu Chen, Xuanming Mao, Luke Zhong, Meizi Tan, Mingyu Cui, Harsh Patel, John N. D. Wurpel, Zhe-Sheng Chen · 2026

Read Umbralisib antagonizes multidrug resistance in ABCB1-overexpressing cancer cells by Letao Bo, Bohan Zhang, Xuan-Yu Chen, Xuanming Mao, Luke Zhong, Meizi Tan, Mingyu Cui, Harsh Patel, John N. D. Wurpel, Zhe-Sheng Chen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13518197.txt.

Description

IntroductionABCB1-mediated multidrug resistance (MDR) reduces the intracellular accumulation of anticancer drugs and limits chemotherapy efficacy. This study investigated whether umbralisib, a dual PI3Kδ/CK1ϵ inhibitor, could reverse ABCB1-mediated MDR.MethodsThe reversal effect of umbralisib was evaluated in ABCB1-overexpressing drug-selected and transfected cell models using MTT assays.

Catalog record

CREATORLetao Bo, Bohan Zhang, Xuan-Yu Chen, Xuanming Mao, Luke Zhong, Meizi Tan, Mingyu Cui, Harsh Patel, John N. D. Wurpel, Zhe-Sheng Chen
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE48 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13518197

Browse the full library · About the Tower of Babel